Development of a Next Generation Visual Performance Assessment System for Rodents
开发下一代啮齿动物视觉表现评估系统
基本信息
- 批准号:9920144
- 负责人:
- 金额:$ 69.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAge related macular degenerationAlgorithmsAlzheimer&aposs DiseaseAnimal TestingAnimalsAutomationBehaviorBehavior assessmentBehavior monitoringBlindnessBrainBrain DiseasesCanadaCerebrumComparative StudyComputational algorithmComputer softwareConeConsumptionContrast SensitivityDevelopmentDevicesDiscriminationDisease modelDrug ScreeningEngineeringEvaluationEyeEye MovementsEye diseasesFutureGene MutationGenerationsGermanyGlaucomaGoalsGrantHeadHead MovementsHistologyInheritedLaboratoriesLegal patentLightLinkManualsMeasurementMeasuresMechanicsMediatingMedicalMethodsMovementMusNerve DegenerationNeurodegenerative DisordersOptical Coherence TomographyParkinson DiseasePathologyPharmaceutical PreparationsPhasePhenotypePhysiologyPoint MutationPositioning AttributeProceduresProcessProtocols documentationRattusReflex actionReproducibilityResearch InstituteResearch PersonnelResolutionRetinaRetinal DegenerationRetinitis PigmentosaRodRodentRodent ModelRunningSmall Business Innovation Research GrantStimulusSystemTabletsTechnologyTestingTimeTransducinTranslatingTranslationsTraumatic Brain InjuryTreatment EfficacyValidationVertebrate PhotoreceptorsVisionVision researchVisualVisual AcuityVisual Pathway DisorderVisual impairmentWild Type Mouseaging brainbasebehavioral phenotypingbehavioral responseblindclinically relevantcommercializationdensitydesigndrug developmentdrug discoverydrug marketeffective therapygazegene functioninnovationluminancemedical schoolsmouse modelnext generationnon-complianceopen sourcepreclinical developmentpreclinical evaluationpreventprototyperesponserhoscale uptooltreatment strategyvalidation studiesvision sciencevisual performancevisual stimulus
项目摘要
7. PROJECT SUMMARY
Title: Development of a Next Generation Visual Performance Assessment System for Rodents
Visual behavior abnormalities not only link directly to the retinal pathology and visual pathway disorders, but also
associate with many neurodegenerative brain conditions, particularly with Alzheimer’s disease, Parkinson’s
disease, and traumatic brain injury. The optomotor reflex (OMR) consists of innate, reflexive head and/or body-
movements during optomotor responses and has been a conventional method for measuring visual functions. It
is emerging as a powerful tool for gene function phenotyping and drug screening in the vision research field,
because it offers noninvasive and clinically-relevant assessments for contrast sensitivity and visual acuity.
As preclinical development and evaluation of treatment strategies for neurodegenerative diseases are highly
dependent on rodent models, especially mouse models, an OMR device for assessing rodent visual performance
is in particular demand. However, existing OMR systems are either subjective (manually-scored OMR) or flawed
as they rely on an arbitrary time window or an unmatched blind animal as a reference to determine vision limits.
Also, the test procedure has not been optimized and is time consuming. The limitations of existing OMR
technology and devices have largely hindered the evaluation of treatment efficacy and gene function behavior
phenotyping in the field of vision science.
In our completed Phase I project (R41 EY025913), we critically addressed the shortcomings of the existing OMR
systems. Our effort has led to a new OMR system which utilizes patent-pending technology. The novelty of our
system lies in the negative OMR indicator that underlies our unique algorithm. ; this algorithm enables
researchers to distinguish between visually-impaired and noncompliant animals. Our optimized testing protocol
uses a staircase reversal procedure, which allows for rapid, unbiased, and fully-automated visual assessment.
The prototype of our system produces efficient and accurate real-time quantification of mouse visual
performance with high sensitivity and reproducibility.
The Specific Aims of this SBIR Phase II project are (1) to develop a “turnkey” OMR system, (2) to validate the
system with multiple retina degenerative mouse models, and authenticate the test protocol as a guide to facilitate
its application, and (3) to refine the system for rod- and cone-specific function discrimination. A platform for
mouse and rat visual behavior assessment will greatly facilitate the drug discovery process aimed at preventing
or slowing vision loss or restoring sight. Thereby, our product will accelerate the development of effective
treatments for devastating blinding conditions including age-related macular degeneration and glaucoma. In the
future, the system will be scaled up, and its application will be expanded to evaluate the aging brain and
neurodegenerative disease models, such as Alzheimer’s disease, by measuring behavior responses toward
various visual stimuli.
7。项目摘要
标题:啮齿动物的下一代视觉性能评估系统的开发
视觉行为异常不仅直接链接到视网膜病理和视觉途径疾病,还可以
与许多神经退行性的大脑状况相关,特别是与阿尔茨海默氏病,帕金森氏病
疾病和创伤性脑损伤。验光反射(OMR)由先天,反身头和/或身体组成
验光响应期间的运动是测量视觉功能的常规方法。它
正在成为视觉研究领域中基因功能表型和药物筛查的强大工具,
因为它为对比度灵敏度和视力提供了无创和临床上的评估。
由于神经退行性疾病的临床前发展和评估是高度
依赖啮齿动物模型,尤其是鼠标模型,一种用于评估啮齿动物视觉性能的OMR设备
特别是需求。但是,现有的OMR系统是主观的(手动评分OMR)或有缺陷
当他们依靠任意时间窗口或无与伦比的盲动物作为确定视觉限制的参考。
同样,测试程序尚未得到优化,并且耗时。现有OMR的局限性
技术和设备在很大程度上阻碍了治疗效率和基因功能行为的评估
视觉科学领域的表型。
在我们完成的I阶段项目(R41 EY025913)中,我们严格解决了现有OMR的缺点
系统。我们的努力导致了一个新的OMR系统,该系统利用了正在申请专利技术的技术。我们的新奇
系统在于基础我们独特算法的负OMR指标。 ;该算法可以启用
研究人员区分视觉障碍和不合格动物。我们优化的测试协议
使用楼梯相反的过程,该过程允许快速,公正和完全自动化的视觉评估。
我们系统的原型可产生小鼠视觉的有效,准确的实时定量
具有高灵敏度和可重复性的性能。
该SBIR II期项目的具体目的是(1)开发“交钥匙” OMR系统,(2)以验证
具有多个视网膜退化鼠标模型的系统,并验证测试方案作为促进的指南
它的应用和(3)用于完善杆和锥体特异性函数歧视的系统。一个平台
鼠标和大鼠视觉行为评估将极大地促进旨在防止的药物发现过程
或视力丧失或恢复视力放缓。因此,我们的产品将加速有效的发展
毁灭性盲目条件的治疗方法,包括与年龄相关的黄斑变性和青光眼。在
未来,该系统将被扩展,并将扩展其应用以评估衰老的大脑和
神经退行性疾病模型,例如阿尔茨海默氏病,通过衡量行为反应
各种视觉刺激。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dong Feng Chen其他文献
Dong Feng Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dong Feng Chen', 18)}}的其他基金
Histone and DNA methyltransferases in optic nerve regeneration
视神经再生中的组蛋白和 DNA 甲基转移酶
- 批准号:
10432811 - 财政年份:2022
- 资助金额:
$ 69.17万 - 项目类别:
Histone and DNA methyltransferases in optic nerve regeneration
视神经再生中的组蛋白和 DNA 甲基转移酶
- 批准号:
10612888 - 财政年份:2022
- 资助金额:
$ 69.17万 - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10298994 - 财政年份:2021
- 资助金额:
$ 69.17万 - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10686336 - 财政年份:2021
- 资助金额:
$ 69.17万 - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10715564 - 财政年份:2021
- 资助金额:
$ 69.17万 - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10584665 - 财政年份:2021
- 资助金额:
$ 69.17万 - 项目类别:
The 7th Military Vision Symposium on Ocular Readiness for Military Conflicts and Civilian Casualties
第七届军事视觉研讨会:军事冲突和平民伤亡的眼部准备
- 批准号:
10156646 - 财政年份:2021
- 资助金额:
$ 69.17万 - 项目类别:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
青光眼发病机制中的先天性和适应性免疫
- 批准号:
10472729 - 财政年份:2021
- 资助金额:
$ 69.17万 - 项目类别:
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration
视神经发育和再生生长的分子基础
- 批准号:
9113192 - 财政年份:2016
- 资助金额:
$ 69.17万 - 项目类别:
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI
TBI 机制和神经保护策略的生物学探究
- 批准号:
7888246 - 财政年份:2009
- 资助金额:
$ 69.17万 - 项目类别:
相似国自然基金
基于“肝—眼轴”的枸杞子及其复方防治青少年近视与年龄相关性黄斑变性的功效物质与生物学机制研究
- 批准号:U21A20408
- 批准年份:2021
- 资助金额:260.00 万元
- 项目类别:
基于“肝-眼轴”的枸杞子及其复方防治青少年近视与年龄相关性黄斑变性的功效物质与生物学机制研究
- 批准号:
- 批准年份:2021
- 资助金额:260 万元
- 项目类别:
PGF突变介导的周细胞与内皮细胞crosstalk在湿性年龄相关性黄斑变性中的作用及机制研究
- 批准号:82000898
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
组织病理结构与临床检查对照观察在指导渗出性年龄相关性黄斑变性诊治中的意义研究
- 批准号:81400409
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于多模态医学影像技术的湿性年龄相关性黄斑变性诊断与分析
- 批准号:81371629
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
相似海外基金
Electronic photoreceptors for restoration of sight in retinal degeneration
电子感光器用于视网膜退化患者恢复视力
- 批准号:
10708374 - 财政年份:2023
- 资助金额:
$ 69.17万 - 项目类别:
NRI: Toward Safe and Reliable Robotic Eye Examinations
NRI:迈向安全可靠的机器人眼科检查
- 批准号:
10671768 - 财政年份:2023
- 资助金额:
$ 69.17万 - 项目类别:
New statistical methods and software for modeling complex multivariate survival data with large-scale covariates
用于对具有大规模协变量的复杂多变量生存数据进行建模的新统计方法和软件
- 批准号:
10631139 - 财政年份:2022
- 资助金额:
$ 69.17万 - 项目类别:
New statistical methods and software for modeling complex multivariate survival data with large-scale covariates
用于对具有大规模协变量的复杂多变量生存数据进行建模的新统计方法和软件
- 批准号:
10453875 - 财政年份:2022
- 资助金额:
$ 69.17万 - 项目类别: